PubRank
Search
About
Dorothea Becker
Author PubWeight™ 27.71
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability.
Cell
2009
1.96
2
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
PLoS One
2009
1.71
3
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas.
Cancer Biol Ther
2005
1.63
4
Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma.
Cell Cycle
2011
1.54
5
SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions.
Cancer Biol Ther
2004
1.24
6
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.
Oncogene
2004
1.18
7
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.
Hum Pathol
2010
1.16
8
Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes.
Cancer Biol Ther
2004
1.16
9
α-Synuclein is localized to mitochondria-associated ER membranes.
J Neurosci
2014
1.13
10
Importance of glycolysis and oxidative phosphorylation in advanced melanoma.
Mol Cancer
2012
1.10
11
Mitochondrial protein import motor: differential role of Tim44 in the recruitment of Pam17 and J-complex to the presequence translocase.
Mol Biol Cell
2008
1.04
12
Pathologic and gene expression features of metastatic melanomas to the brain.
Cancer
2013
1.01
13
Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy.
EMBO Rep
2013
0.98
14
Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis.
Mol Med
2002
0.95
15
Mitochondrial respiration--an important therapeutic target in melanoma.
PLoS One
2012
0.95
16
Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein.
J Invest Dermatol
2009
0.93
17
The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion.
Cancer Biol Ther
2006
0.90
18
Proteomic analysis of laser microdissected melanoma cells from skin organ cultures.
J Proteome Res
2010
0.90
19
Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation.
Cancer Biol Ther
2009
0.87
20
Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma.
Genes Cancer
2010
0.85
21
Structure and function of Hsp78, the mitochondrial ClpB homolog.
J Struct Biol
2006
0.84
22
The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas.
Mol Cancer
2012
0.83
23
Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C.
J Invest Dermatol
2012
0.82
24
New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.
Am J Pathol
2002
0.79
25
Fluorescence imaging analysis of upstream regulators and downstream targets of STAT3 in melanoma precursor lesions obtained from patients before and after systemic low-dose interferon-alpha treatment.
Mol Imaging
2003
0.77
26
Molecular therapy for melanoma: useful and not useful targets.
Cancer Biol Ther
2010
0.76